Search by Drug Name or NDC

    NDC 67877-0458-12 Capecitabine 150 mg/1 Details

    Capecitabine 150 mg/1

    Capecitabine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is CAPECITABINE.

    Product Information

    NDC 67877-0458
    Product ID 67877-458_f289256e-b3d1-497c-b774-6284c6641c8e
    Associated GPIs 21300005000320
    GCN Sequence Number 039780
    GCN Sequence Number Description capecitabine TABLET 150 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 31611
    HICL Sequence Number 018385
    HICL Sequence Number Description CAPECITABINE
    Brand/Generic Generic
    Proprietary Name Capecitabine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Capecitabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name CAPECITABINE
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207652
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0458-12 (67877045812)

    NDC Package Code 67877-458-12
    Billing NDC 67877045812
    Package 120 TABLET, FILM COATED in 1 BOTTLE (67877-458-12)
    Marketing Start Date 2017-11-25
    NDC Exclude Flag N
    Pricing Information N/A